Transmission of hepatitis C via both erythrocyte and platelet transfusions from a single donor in serological window-phase of hepatitis C

Vox Sanguinis

Volumn 71, Issue 1, 1996, Pages 55-57

  Widell, Anders ^a   Elmud, Henrik ^b   Persson, Mats Hugo ^c   Jonsson, Maímu ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b CENTRAL HOSPITAL   (Sweden)

^c City Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD DONOR; CASE REPORT; ERYTHROCYTE TRANSFUSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCUBATION TIME; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; THROMBOCYTE TRANSFUSION; VIRUS TRANSMISSION;

EID: 0029882401     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1996.7110055.x     Document Type: Article

References (10)

1. Widell A, Månsson AS, Sundström G, Hansson BG, Nordenfeit E: Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays. J Med Virol 1991;35:253-258.
2. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, Pucell RH: The natural history of infection with hepatitis C virus (HCV) in chimpanzees: Comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis 1992;165:1006-1011.
3. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions: Infectious disease testing for blood transfusions. JAMA 1995;274:1374-1379.
4. Widell A, Shev S, Månsson S, Zhang YY, Foberg U, Norkrans G, Frydén A, Weiland O, Kurkus J, Nordenfelt E: Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type-specific primers: Epidemiological applications. J Med Virol 1994; 44:272-279.
5. Vrielink H, van der Poel CL, Reesink HW, Zaijer HL, Lelie PN: Transmission of hepatitis C virus by anti-HCV negative blood transfusion. Vox Sang 1995;68:55-56.
6. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger S: Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon-α therapy in chronic hepatitis C. Hepatology 1995;22:1050-1056.
7. Sugitani M, Inchauspe G, Shindo M, Prince AM: Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992;339:1018-1019.
8. Lai ME, Argiolu F, Farci P, Lisci V, Mazzoleni AR Dessi C, Coiana A, Tronci MB, De Virgilis S, Arnone M, Balestrieri A, Cao A: Transfusion-associated hepatitis in polytransfused thalassemic children following the introduction of anti-HCV donor screening in Sardinia; in Nishioka K, Suzuki H, Mishiro S, Oda T (eds): Viral Hepatitis and Liver Disease. Proc Int Symp Viral Hepatitis and Liver Disease. Tokyo, Springer, 1994, pp 558-561.
9. Widell A, Sundström G, Hansson BG, Fex G, Moestrup T, Nordenfelt E: Relation between donor transaminase and recipient hepatitis type non-A,non-B in Sweden. Vox Sang 1988;54: 154-159.
10. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis. Natau Med 1995;1:564-569.